
Nazli Tokatli
Istanbul Health and Technology University
AI and Digital Ophthalmology examines how artificial intelligence, data science, telemedicine, and connected technologies are transforming eye care. The session includes machine learning, automated screening, image analysis, clinical decision support, remote monitoring, digital workflows, health-data integration, and responsible implementation of emerging digital tools.
Abstract Scope and Participation
Abstracts may cover AI algorithms, machine learning, automated diagnostics, teleophthalmology, digital platforms, predictive modeling, clinical validation, implementation, ethics, and responsible AI. Ophthalmologists, data scientists, engineers, researchers, clinicians, technology developers, and digital-health professionals are invited to contribute.

Istanbul Health and Technology University
Glaucoma represents a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage that often progresses asymptomatically until significant vision loss occurs.…
Background: Artificial Intelligence (AI) tools, particularly Large Language Models (LLMs), are increasingly utilised to provide health information, with patients seeking simplified explanations of…
The rising global burden of vision-threatening conditions highlights the need for scalable, accessible, and accurate screening tools. RetinX is an AI-powered mobile application developed to address…
Background: Glaucoma, the leading cause of irreversible blindness, demands early diagnosis and consistent monitoring, which remain difficult due to the subjectivity of traditional assessments.…
Background: Most deep learning systems for Diabetic Retinopathy (DR) screening rely on architectures such as ResNet and EfficientNet, with recent attention shifting towards transformer-based models.…
Introduction: Big Data and AI are transforming ophthalmology, particularly in the early detection of Diabetic Retinopathy (DR). Leveraging vast datasets and machine learning, these technologies…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original AI and Digital Ophthalmology work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping AI and Digital Ophthalmology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The AI and Digital Ophthalmology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in AI and Digital Ophthalmology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in AI and Digital Ophthalmology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the AI and Digital Ophthalmology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.